Company | Cap $ | P/E | P/B | P/S | ROE | ROA | ROS | L/A | P/FCF | PR | Period |
---|---|---|---|---|---|---|---|---|---|---|---|
10X Genomics | 3,303 | 2023q3 | |||||||||
2seventy bio | 229 | 2023q3 | |||||||||
ACADIA Pharmaceuticals | 3,566 | 2023q1 | |||||||||
ADC Therapeutics | 121 | 2023q2 | |||||||||
ADMA Biologics | 1,421 | 2023q3 | |||||||||
ANI Pharmaceuticals | 1,422 | 2023q3 | |||||||||
ARCA biopharma | 26 | 2023q3 | |||||||||
AbCellera Biologics | 1,332 | 2023q3 | |||||||||
AbbVie | 293,959 | 2023 | |||||||||
Abbott Laboratories | 193,498 | 2023q2 | |||||||||
Abeona Therapeutics | 131 | 2022 | |||||||||
Accolade, Inc. (Pennsylva... | 635 | 2022q3 | |||||||||
Accuray | 247 | 2024q2 | |||||||||
Achilles Therapeutics | 52 | 2023q3 | |||||||||
Adaptive Biotechnologies | 621 | 2023q3 | |||||||||
Addus HomeCare | 1,677 | 2023q1 | |||||||||
Affimed | 596 | 2021 | |||||||||
Agilent Technologies | 43,601 | 2023q1 | |||||||||
Agios Pharmaceuticals | 1,633 | 2022 | |||||||||
AirSculpt Technologies | 331 | 2023q3 |